Drugs Made In America Acquisition II Corp. Unit DMIIU NASDAQ

NASDAQ Global Select • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value

N/A

Negative cash flow

股票統計 — DMIIU

Drugs Made In America Acquisition II Corp. Unit (DMIIU) 的市值為 $633.96M 交易價格為 $10.06. 52週價格區間為 9.935-10.8.

該股票擁有 Beta值為 0.24, 營運於 Financial Services 板塊.

交易數據

當前價格$10.06

52週區間9.935-10.8

成交量1K

30日平均成交量3.69K

市值$633.96M

Beta（1年）0.24

公司

IPO Date2025-09-25

Employees2

CEORoger Bendelac

國家US

交易所NASDAQ Global Select

貨幣USD

ISINKYG2851K1206

CUSIPG2851K120

損益（最近年度）

資產負債表（最近年度）

估値比率

其他人也在看

GAM

General American Investors Company, Inc.

$62.90

+0.61%

NCDL

Nuveen Churchill Direct Lending Corp.

$14.42

+2.85%

GAIN

Gladstone Investment Corporation

$15.36

+1.45%

MSIF

MSC Income Fund, Inc.

Eagle Point Income Company Inc.

$9.82

+1.45%

OCCI

OFS Credit Company, Inc.

$2.98

-1.65%

VITSX

Vanguard Total Stock Market Index Fund Institutional Shares

$166.82

+1.15%

Drugs Made In America Acquisition II Corp. Unit DMIIU NASDAQ

股票統計 — DMIIU

其他人也在看

獲取低估股票提醒